The firm, which has made significant investments into its U.S. arm in recent years, was one of 20 firms named in a Trump-directed letter that expressed “concern” over practices that “may entail unlawful disparate treatment” based on “sex, race or other protected characteristics”.
The firm, which has made significant investments into its U.S. arm in recent years, was one of 20 firms named in a Trump-directed letter that expressed “concern” over practices that “may entail unlawful disparate treatment” based on “sex, race or other protected characteristics”.
